Gulf Times - Alzheimer-s-drug
First patient set to receive controversial Biogen Alzheimer's drug

First patient set to receive controversial Biogen Alzheimer's drug

A US hospital on Wednesday will give the first infusion of an expensive, controversial new Alzheimer's drug from Biogen Inc before Medicare had even said what it will pay for - and with some doctors upset by its approval last week.